NRG1 fusions: Biology to therapy.

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Stephen V Liu

Abstract

NRG1 fusions are rare oncogenic drivers that exist at low frequencies across multiple tumor types. They are uncommon in lung cancer with an estimated incidence of 0.2 %. NRG1 fusions have a unique biology and are challenging to detect, due to large intronic regions of the gene, but they do represent possible therapeutic targets. Several agents targeting the ErbB signaling pathway have shown early evidence of efficacy including pan-ErbB kinase inhibitors, monoclonal antibodies, and bispecific antibodies. Supporting data are limited to case reports and small series for now, but prospective trials are underway. While our understanding of these fusions is still evolving, it is clear that NRG1 will be a clinically relevant finding in the years to come.

References

Mar 22, 2003·Experimental Cell Research·Douglas L Falls
Jan 29, 2014·Cancer Discovery·Lynnette Fernandez-CuestaRoman K Thomas
Apr 15, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takashi NakaokuTakashi Kohno
Jul 23, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hyo Sup ShimA John Iafrate
Aug 31, 2016·Lancet·Fred R HirschLuis Paz-Ares
May 16, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nathan D GayKhaled Tolba
Sep 28, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R JonesJ Laskin
Nov 25, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Parneet K CheemaMing-Sound Tsao
Jan 27, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jessica J LinSai-Hong Ignatius Ou
Apr 4, 2018·Cancer Discovery·Alexander DrilonGopinath Ganji
Apr 11, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Caroline E McCoachRobert C Doebele
May 29, 2018·Cancer Discovery·Christoph HeiningHanno Glimm
Oct 1, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hye Sook KimI James
Apr 17, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sushma JonnaStephen V Liu
Apr 28, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ryma BenayedMarc Ladanyi
Jun 5, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kurtis D Davies, Dara L Aisner
Jun 13, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anastasios Dimou, D Ross Camidge
Aug 28, 2020·The Oncologist·Jacques CadranelDaniel J Renouf
Dec 24, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adriana Estrada-BernalRobert C Doebele
Jan 9, 2021·Breast Cancer Research : BCR·Karen D HowarthPaul A W Edwards
Jun 3, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander DrilonJacques Cadranel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
J LaskinM Duruisseaux
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Honggang KeShun Lu
Breast Cancer Research : BCR
Karen D HowarthP A W Edwards
ResearchSquare
Karen D HowarthP A W Edwards
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Martin R JonesD J Renouf
© 2021 Meta ULC. All rights reserved